The grant from the California Institute of Regenerative Medicine will fund research on two approaches to DMD gene therapy using CRISPR/Cas9.
A bacterial argonaute protein is being touted as a DNA-guided, DNA-targeting genome editor, but some scientists are having trouble reproducing those results.
The researchers also developed a mouse model of the mutation using CRISPR/Cas9 genome engineering to examine its effects.
While reimbursement and regulatory issues may make some cautious, investors are encouraged by the promise of breakthrough outcomes in a variety of applications.
Evotec may use the technology for its drug-development and R&D activities, including in the development of research tools and in target identification.
In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.
Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.
A startup company is offering a test to analyze soil samples from farms for pathogens.
Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.